This HTML5 document contains 205 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1093/NEUONC/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35170361
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel artykuł naukowy tudományos cikk wissenschaftlicher Artikel vitenskapelig artikkel 2011年論文 2011年论文 bài báo khoa học 2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած 2011 nî lūn-bûn articol științific научни чланак artikulong pang-agham 2011年论文 บทความทางวิทยาศาสตร์ vitskapeleg artikkel artículo científico publicado en 2011 articolo scientifico artigo científico (publicado na 2011) article scientific artículu científicu espublizáu en 2011 სამეცნიერო სტატია 2011年の論文 مقالة علمية 2011年论文 научная статья scienca artikolo 2011年論文 ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ مقالهٔ علمی 2011年論文 tieteellinen artikkeli 2011 թվականի հուլիսին հրատարակված գիտական հոդված 2011年论文 mokslinis straipsnis научни чланак سائنسی مضمون scientific article bilimsel makale artikull shkencor 2011년 논문 naučni članak artigo científico (publicado na 2011) מאמר מדעי επιστημονικό άρθρο teaduslik artikkel article científic 2011年论文 научна статия 2011年論文 article scientifique (publié 2011) artigo científico videnskabelig artikel (udgivet 2011) 2011年論文 vedecký článok наукова стаття, опублікована в липні 2011 мақолаи илмӣ wetenschappelijk artikel 2011年论文 vědecký článek
p:P577
wds:Q35170361-7F8A6044-DFBF-4025-87EB-042812B41F1C
wdt:P577
2011-07-15T00:00:00Z
p:P2860
wds:Q35170361-FDB5C324-767F-43DD-AB15-4B8DF322D12B wds:Q35170361-FDD9D209-4BF4-4E52-90F7-759D6534EF3E wds:Q35170361-C66E6C62-250E-4D0A-855C-1238A2E6351D wds:Q35170361-C6DFD612-E271-4C5E-B230-5B0FB9F3B92B wds:Q35170361-CA2DFAA9-7F8A-4A67-9816-3FA4B9E5CF07 wds:Q35170361-CE78739F-5BDD-4029-B58C-AC64978A9CB8 wds:Q35170361-BFF79AF2-6916-4AD8-93B3-750C7F7F3746 wds:Q35170361-C2954DCF-8976-4158-9B8E-6C49C7A47F2D wds:Q35170361-DA595D18-5B68-48D0-BE95-04F08F1B2A9F wds:Q35170361-F27E91E8-C97A-4AAA-9E49-F29AFE75EAA4 wds:Q35170361-D6F34FD4-1A4D-4885-BB60-B5BA8316761E wds:Q35170361-D94EAA9A-22FA-4D40-AA29-A8260A2CCC7B wds:Q35170361-878494CE-CD65-4BA5-9EF0-08FF4296A7CC wds:Q35170361-90F2D8B8-E46D-45E0-84FB-B19090632BD1 wds:Q35170361-91874118-5CAF-455A-992E-C96B619E7F1E wds:Q35170361-775F2262-013F-4F02-A518-B29A7385F1BB wds:Q35170361-847D4150-BF0E-4BBE-993E-1CA8F800C92A wds:Q35170361-9F0D7AA4-14F6-4A53-96F7-280D6F8B7950 wds:Q35170361-A6A3E036-459B-4014-BB8A-99711C1718E3 wds:Q35170361-B0096F00-AF07-4860-A982-248026552328 wds:Q35170361-925D2DC6-DCAB-4B2B-AFEB-85E73E40CCB6 wds:Q35170361-936B868D-F2F1-4336-AB4A-F0D7854A2F2A wds:Q35170361-9C31203E-D323-4722-B3A9-7BF88526D92F wds:Q35170361-5348441C-FA70-487B-A977-FB92962F322D wds:Q35170361-562AA39E-D2BA-44E7-BF16-CC89B087A923 wds:Q35170361-5D6E2A8F-42A4-40F9-B8B9-EFC61F9C4B09 wds:Q35170361-3983D5E7-B953-45DA-87B9-9A148EBA4018 wds:Q35170361-40262406-7130-4752-BBB1-511A0CE1337F wds:Q35170361-53340ACA-F108-47AB-912F-3FC2A9F82A0C wds:Q35170361-6F2B9FEA-0632-4B32-8B60-D0F769FF26B8 wds:Q35170361-70F4F125-1950-45E9-B60D-5BD8C1B69A1F wds:Q35170361-74A526BC-3783-4479-AEBC-A2B49B218737 wds:Q35170361-5DE1D808-2B1F-4BD3-8926-4358870C93A3 wds:Q35170361-63EC4325-1229-4413-91C9-1590DE8E00D1 wds:Q35170361-65AFFE09-42FE-4B95-AE85-FCD34629D2B9 wds:Q35170361-6CBDAB70-03C9-43E6-A5A3-3D9E17453E66 wds:Q35170361-069E2B50-A092-4121-9D8F-1274FFEF3D39 wds:Q35170361-0899A4AC-B1EE-4CB2-9C15-7343F746EECE wds:Q35170361-0BBA2C26-D5DC-4D77-BEFD-44B4BFEC798D wds:Q35170361-1F1E5C2F-DE9B-4315-9AC3-6F0F72F05DC7 wds:Q35170361-03418E4C-106B-42CC-8D32-B5B36D8B7EA6 wds:Q35170361-061ECE14-80D2-4BB3-90F4-04CE55976D7A wds:Q35170361-28A33159-8B63-4D2B-8937-29AC9A869B9A wds:Q35170361-37BAAF70-5345-4273-A972-048A73E9736E wds:Q35170361-393640DD-7425-43A2-BF1D-04801D150FF9 wds:Q35170361-20466D80-04AB-4105-A195-33C05B777012 wds:Q35170361-270D970A-D827-4E86-A66A-678EBB4588DB
wdt:P2860
wd:Q40487763 wd:Q70083436 wd:Q33557565 wd:Q37047723 wd:Q43116317 wd:Q43257194 wd:Q27824832 wd:Q34164315 wd:Q34149540 wd:Q37738770 wd:Q43120613 wd:Q43688734 wd:Q71971336 wd:Q36084509 wd:Q24522838 wd:Q34533605 wd:Q39527105 wd:Q35073541 wd:Q40301376 wd:Q51659035 wd:Q46103428 wd:Q33356338 wd:Q34234535 wd:Q39153809 wd:Q39153817 wd:Q66979079 wd:Q71268146 wd:Q29547224 wd:Q34600929 wd:Q33671660 wd:Q45121044 wd:Q34132099 wd:Q37204028 wd:Q39686229 wd:Q35626507 wd:Q39566231 wd:Q34639817 wd:Q34278624 wd:Q29618049 wd:Q48237821 wd:Q73348370 wd:Q48230300 wd:Q39560991 wd:Q52606873 wd:Q34457655 wd:Q71971315 wd:Q43487486
p:P2093
wds:Q35170361-2D3C02EF-08AE-4B35-9EB6-95E01ECB2AE1 wds:Q35170361-B61B9DBE-DBA3-4A9C-8581-EBFE3FDB7FCF wds:Q35170361-D1826134-9330-4969-A16F-09ED29BE9943 wds:Q35170361-F3501272-C1EE-4B2D-A323-EC738ACFA816 wds:Q35170361-DC086143-EDAF-4F93-919E-AF2680904331
wdt:P2093
Colette M Aprhys Gary L Gallia Gregory J Riggins Ren-Yuan Bai Verena Staedtke
rdfs:label
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
skos:prefLabel
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
schema:name
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
p:P1476
wds:Q35170361-F57A6473-1789-40A4-BEE1-65FFD25D0C9B
wdt:P1476
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
p:P304
wds:Q35170361-8B493245-E73E-44E3-AE13-F04006C61F02
wdt:P304
974-982
p:P31
wds:Q35170361-540F4E05-8726-4A2E-B229-A54A66784628
wdt:P31
wd:Q13442814
p:P921
wds:Q35170361-2284E143-7699-4814-85A2-C0F3045C5BB8 wds:Q35170361-D9579D7D-37B1-454A-ABC3-3D5F0C7A7F40
wdt:P921
wd:Q282142 wd:Q422194
p:P698
wds:Q35170361-C1DA1D38-C553-4B77-9BA3-3665D765CBB5
wdtn:P698
n12:21764822
wdt:P698
21764822
p:P1433
wds:Q35170361-70CC1FF6-8992-485B-BE5D-A778FB9A3E1C
wdt:P1433
wd:Q15724471
p:P433
wds:Q35170361-9EFA1D31-DB69-41AD-8B68-E9C09A7072E9
p:P478
wds:Q35170361-202E15D3-6448-4413-9971-BA8DA95E1ABB
wdt:P433
9
wdt:P478
13
p:P356
wds:Q35170361-03995DD8-C01C-4BD6-A5D4-2ED9CECEFD58
wdtn:P356
n9:NOR077
wdt:P356
10.1093/NEUONC/NOR077
p:P5875
wds:Q35170361-45B0AE04-166A-4F01-8928-79AFA128433C
wdt:P5875
51498097
p:P4510
wds:Q35170361-7527E7C4-A265-4580-8952-CA81DE87DD99
wdt:P4510
wd:Q1659584
p:P932
wds:Q35170361-A3AC9639-63A4-4376-B7FE-9BE61112A815
wdt:P932
3158014